Kim Statham Ringen on the Importance of Meeting Other Survivors

A friend of mine is strong in her faith and is living well with a stage 4 cancer diagnosis. She is someone I look up to in these matters.

Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.

I was told that after five years in remission, my cancer would be behind me. However, I was not told what life would be like after that milestone.

February brought in multiple FDA approvals in the oncology space. Here’s an overview of some of the most recent ones.

A computer model may help predict which patients with breast cancer are more likely to experience neuropathy from taxane therapies.

During summer 2024, there have been many changes made in the non-small cell lung cancer and small cell lung cancer spaces. Here are four top news stories.